These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 21399657)

  • 1. Mutation of thyroid hormone receptor-β in mice predisposes to the development of mammary tumors.
    Guigon CJ; Kim DW; Willingham MC; Cheng SY
    Oncogene; 2011 Jul; 30(30):3381-90. PubMed ID: 21399657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of TSH in the spontaneous development of asymmetrical thyroid carcinoma in mice with a targeted mutation in a single allele of the thyroid hormone-β receptor.
    Zhao L; Zhu X; Won Park J; Fozzatti L; Willingham M; Cheng SY
    Endocrinology; 2012 Oct; 153(10):5090-100. PubMed ID: 22919057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of beta-catenin by a novel nongenomic action of thyroid hormone beta receptor.
    Guigon CJ; Zhao L; Lu C; Willingham MC; Cheng SY
    Mol Cell Biol; 2008 Jul; 28(14):4598-608. PubMed ID: 18474620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stat5 regulates the phosphatidylinositol 3-kinase/Akt1 pathway during mammary gland development and tumorigenesis.
    Schmidt JW; Wehde BL; Sakamoto K; Triplett AA; Anderson SM; Tsichlis PN; Leone G; Wagner KU
    Mol Cell Biol; 2014 Apr; 34(7):1363-77. PubMed ID: 24469394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic signaling of KRAS and thyroid hormone receptor β mutants promotes undifferentiated thyroid cancer through MYC up-regulation.
    Zhu X; Zhao L; Park JW; Willingham MC; Cheng SY
    Neoplasia; 2014 Sep; 16(9):757-69. PubMed ID: 25246276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diet-induced obesity increases tumor growth and promotes anaplastic change in thyroid cancer in a mouse model.
    Kim WG; Park JW; Willingham MC; Cheng SY
    Endocrinology; 2013 Aug; 154(8):2936-47. PubMed ID: 23748362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PTEN deficiency accelerates tumour progression in a mouse model of thyroid cancer.
    Guigon CJ; Zhao L; Willingham MC; Cheng SY
    Oncogene; 2009 Jan; 28(4):509-17. PubMed ID: 18997818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A tumor suppressor role for thyroid hormone beta receptor in a mouse model of thyroid carcinogenesis.
    Kato Y; Ying H; Willingham MC; Cheng SY
    Endocrinology; 2004 Oct; 145(10):4430-8. PubMed ID: 15231697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of STAT3 signaling blocks obesity-induced mammary hyperplasia in a mouse model.
    Park JW; Zhao L; Willingham MC; Cheng SY
    Am J Cancer Res; 2017; 7(3):727-739. PubMed ID: 28401024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of the tumor suppressor gene phosphatase and tensin homologue partially inhibits wnt-1-induced mammary tumorigenesis.
    Zhao H; Cui Y; Dupont J; Sun H; Hennighausen L; Yakar S
    Cancer Res; 2005 Aug; 65(15):6864-73. PubMed ID: 16061670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multi-tissue gene-expression analysis in a mouse model of thyroid hormone resistance.
    Miller LD; McPhie P; Suzuki H; Kato Y; Liu ET; Cheng SY
    Genome Biol; 2004; 5(5):R31. PubMed ID: 15128445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of tumor cell proliferation by thyroid hormone in a mouse model of follicular thyroid carcinoma.
    Lu C; Zhu X; Willingham MC; Cheng SY
    Oncogene; 2012 Apr; 31(16):2007-16. PubMed ID: 21909131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Marked potentiation of the dominant negative action of a mutant thyroid hormone receptor beta in mice by the ablation of one wild-type beta allele.
    Suzuki H; Zhang XY; Forrest D; Willingham MC; Cheng SY
    Mol Endocrinol; 2003 May; 17(5):895-907. PubMed ID: 12576488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of STAT3 activity delays obesity-induced thyroid carcinogenesis in a mouse model.
    Park JW; Han CR; Zhao L; Willingham MC; Cheng SY
    Endocr Relat Cancer; 2016 Jan; 23(1):53-63. PubMed ID: 26552408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel oncogenic actions of TRbeta mutants in tumorigenesis.
    Guigon CJ; Cheng SY
    IUBMB Life; 2009 May; 61(5):528-36. PubMed ID: 19391168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncogenic AKT1(E17K) mutation induces mammary hyperplasia but prevents HER2-driven tumorigenesis.
    Mancini ML; Lien EC; Toker A
    Oncotarget; 2016 Apr; 7(14):17301-13. PubMed ID: 27004402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SAHA-induced loss of tumor suppressor Pten gene promotes thyroid carcinogenesis in a mouse model.
    Zhu X; Kim DW; Zhao L; Willingham MC; Cheng SY
    Endocr Relat Cancer; 2016 Jul; 23(7):521-33. PubMed ID: 27267120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An unliganded thyroid hormone beta receptor activates the cyclin D1/cyclin-dependent kinase/retinoblastoma/E2F pathway and induces pituitary tumorigenesis.
    Furumoto H; Ying H; Chandramouli GV; Zhao L; Walker RL; Meltzer PS; Willingham MC; Cheng SY
    Mol Cell Biol; 2005 Jan; 25(1):124-35. PubMed ID: 15601836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of tyrosine phosphorylation at Y406 abrogates the tumor suppressor functions of the thyroid hormone receptor β.
    Park JW; Zhao L; Willingham MC; Cheng SY
    Mol Carcinog; 2017 Feb; 56(2):489-498. PubMed ID: 27254276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reactivation of the silenced thyroid hormone receptor β gene expression delays thyroid tumor progression.
    Kim WG; Zhu X; Kim DW; Zhang L; Kebebew E; Cheng SY
    Endocrinology; 2013 Jan; 154(1):25-35. PubMed ID: 23183175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.